| 001 - CONTROL NUMBER |
|---|
| control field |
EBL1798300 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| additional material characteristics |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr -n--------- |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
141019s2014||||||| s|||||||||||eng|d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780124079014 |
| Terms of availability |
161.91 (UA) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(AU-PeEL)1798300 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)892240074 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
AU-PeEL |
| Language of cataloging |
eng |
| Transcribing agency |
AU-PeEL |
| Modifying agency |
AU-PeEL |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RG627.6 .D79 D796 2014 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
618.32 |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (OCLC) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
RG627.6 .D79 D796 2014 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Schaefer, Christof. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Drugs During Pregnancy and Lactation : |
| Remainder of title |
Treatment Options and Risk Assessment |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
3rd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Burlington : |
| Name of publisher, distributor, etc |
Elsevier Science, |
| Date of publication, distribution, etc |
2014. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (919 p.) |
| 490 0# - SERIES STATEMENT |
|---|
| Series statement |
eBooks on Demand |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Cover; Drugs During Pregnancy and Lactation; Copyright; Contents; List of Contributors; Preface; Disclaimer; 1 - General commentary on drug therapy and drug risks in pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics of drugs in pregnancy; 1.8 Mechanisms of developmental toxic agents; 1.9 Causes of developmental disorders; 1.10 Embryo/fetotoxic risk assessment and plausibility |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1.11 Classification of drugs used in pregnancy1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety of drugs already used in pregnancy; 1.16 Teratology information centers; References; 2 - Specific drug therapiesduring pregnancy; 2.1 - Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Acetylsalicylic acid; 2.1.3 Pyrazolone compounds and phenylbutazone |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
2.1.4 Analgesic drug combination products and drugs used for osteoarthritis2.1.5 Opioid agonists and antagonists and other centrally acting analgesics; 2.1.6 Non-steroidal anti-inflammatory and antirheumatic drugs; 2.1.7 Migraine therapy; 2.1.8 Muscle relaxants and other analgesics; 2.1.9 Antigout preparations; References; 2.2 - Allergy and hyposensitization therapy; 2.2.1 Antihistamines (H1-blocker); 2.2.2 Hyposensitization therapy; 2.2.3 C1-Esterase inhibitor deficiency; References; 2.3 - Antiasthmatic and cough medication; 2.3.1 Selective β2-adrenergic agonists |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
2.3.2 Inhaled corticosteroids (ICSs)2.3.3 Theophylline; 2.3.4 Leukotriene antagonists; 2.3.5 Mast cell stabilizers (inhibitors); 2.3.6 Anticholinergics; 2.3.7 Omalizumab and roflumilast; 2.3.8 Expectorants and mucolytic agents; 2.3.9 Antitussives; 2.3.10 Non-selective β-adrenergic agonists; References; 2.4 - Nausea and vomiting in pregnancy; 2.4.1 Treatment options; 2.4.2 Complementary treatment options; 2.4.3 Pharmacological treatment options; 2.4.4 Dopamine antagonists; 2.4.5 Pyridoxine (vitamin B6); 2.4.6 Vitamin B1; 2.4.7 Serotonin antagonists; 2.4.8 Glucocorticoids |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
2.4.9 Other antiemeticsSummary; References; 2.5 - Gastro-intestinal medications, hypolipidemic agents and spasmolytics; 2.5.1 Antacids; 2.5.2 Sucralfate and pirenzepine; 2.5.3 H2 receptor antagonists; 2.5.4 Proton pump inhibitors; 2.5.5 Bismuth salts; 2.5.6 Helicobacter pylori therapy; 2.5.7 Digestives and carminatives; 2.5.8 Atropine and other anticholinergic spasmolytics; 2.5.9 Cholinergics; 2.5.10 Constipation during pregnancy; 2.5.11 Antidiarrheal agents; 2.5.12 Medications for inflammatory bowel disease; 2.5.13 Chenodeoxycholic acid and ursodeoxycholic acid; 2.5.14 Lipid lowering agents |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
2.5.15 Appetite suppressants, weight loss medications, and obesity |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Drugs During Pregnancy and Lactation, 3rd Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who prescribe or deliver medicinal products, and to those who evaluate health and safety risks. Each chapter contains twofold information regarding drugs that are appropriate for prescription during pregnancy and an assessment of the risk of a drug when exposure during pregnancy has already occurred. Thoroughly updated with current regulations, references to the latest pharmacological data, and new |
| 588 ## - |
|---|
| -- |
Description based upon print version of record. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Fetus -- Effect of drugs on -- Handbooks, manuals, etc. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Newborn infants -- Effect of drugs on -- Handbooks, manuals, etc. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Obstetrical pharmacology -- Handbooks, manuals, etc. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pregnant women -- Drug use. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pregnant women -- Medical care. |
| 655 #0 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Peters, Paul W.J. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Miller, Richard K. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Print version: |
| Main entry heading |
Schaefer, Christof |
| Title |
Drugs During Pregnancy and Lactation : Treatment Options and Risk Assessment |
| Place, publisher, and date of publication |
Burlington : Elsevier Science,c2014 |
| International Standard Book Number |
9780124080782 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="http://uttyler.eblib.com/patron/FullRecord.aspx?p=1798300">http://uttyler.eblib.com/patron/FullRecord.aspx?p=1798300</a> |
| Link text |
Click here to view this ebook. |
| 901 ## - LOCAL DATA ELEMENT A, LDA (RLIN) |
|---|
| Platform |
EBL |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Electronic Book |
| Source of classification or shelving scheme |
|
